A Clinical Evaluation for the Management of Patients with Major Depressive Disorder, single or recurrent episode, with Deep Brain Stimulation: The BROADEN Study

Aims and Objectives

To evaluate the safety and efficacy of Deep Brain Stimulation for patients with MDD, who have failed to respond to at least 4 treatments in the current episode. The primary outcome assessment will occur at 6 months and all patients will be followed-up for 1 year.

Study Details

The study will compare group 1 who will be implanted with the device and activated for stimulation and group 2 (the control group) who will be implanted with the device but will not receive active stimulation for the first six months of the study. This study will also aim to describe the effects of DBS on measures of regional brain metabolic activity using electroencephalography (EEG) and PET (positron emission tomography) scanning.

The study is ongoing.

More Information

More details can be found on the BROADEN Study website (external link).

Primary Investigator:

Professor Keith Matthews


Last Updated on Wednesday, 10 July 2013 01:40

National Services Scotland

Advanced Interventions Service
Area 7, Level 6
South Block
Ninewells Hospital and Medical School
Dundee, DD1 9SY. UK.
Tel: +44 (0)1382 496233

NHS Tayside LogoSpacer 40x80Dundee University Logo